Particle.news

Download on the App Store

AOK Study Finds Wide Regional Gaps and Persistent Benzodiazepine Overuse in German Nursing Homes

A seven-year review of AOK records highlights modest drops in sedative use alongside alarming shortfalls in diabetes eye care.

Image
Bei der Qualität der Pflege in Heimen gibt es große regionale Unterschiede. Dabei geht es beispielsweise um die Dauermedikation mit Schlaf- und Beruhigungsmitteln, wie aus einer Auswertung des wissenschaftlichen Instituts der AOK hervorgeht.
Image

Overview

  • Analysis of data from around 350,000 residents reveals pronounced differences in care quality across Germany’s federal states.
  • In 2023, 7.14% of nursing home residents received long-term benzodiazepine prescriptions, down slightly from 7.33% in 2022.
  • Sedative use peaks at 15.88% in Saarland and falls to just 2.9% in Saxony-Anhalt, with North Rhine-Westphalia reporting 12.15%, five points above the national average.
  • Long-term benzodiazepine therapy poses risks of dependency, increased falls, anxiety and depression among elderly residents.
  • More than 79% of nursing home residents with diabetes did not receive regular ophthalmological screening in 2023.